Clinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.

Japanese pharmaceutical company developing prescription drugs, infectious disease therapies, and specialty medicines, including a former sleep apnea drug joint venture with Apnimed.